$ホロジック(HOLX.US)$Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography 3 MINUTES AGO, 2:07 PM EDT VIA BUSINESSWIRE Collaboration Includes Robust Education and Training to Support Radiologists and Imaging Specialists Bayer and Hologic, Inc. (NASDAQ:HOLX) today announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The two ...
Multiple insiders selling shares could be a red flag. The absence of insider purchases and significant selling over the last three months may suggest insiders believe the shares are overpriced. Despite high insider ownership, the lack of buying and significant selling raises concerns about the company.
Undervalued Hologic presents opportunity to accumulate stocks. Investors cautioned to consider financial health. Company's outlook suggests further growth not reflected in share price.
Trytosaveabit :
@FrankieSmilez I know this is a old post from you! But I just found it! Hehehe. Would have made me more comfortable with my decision to take a position back on the 18th of July! Hehehe. It worked out nicely but still! Hehehe. I see you also have $デア・バイオサイエンス (DARE.US)$ in this comment! Another I’m swinging! Hope you having a great day? Haven’t heard much from you since early ?
FrankieSmilezスレ主Trytosaveabit:
Femy took off today I've been eyeing the news on this sector and it finally gained some traction. I agree Dare is another good one
Gapping up $ビザ(V.US)$+1.1%,$マスターカード(MA.US)$+1.7% (Keybanc upgraded their ratings to overweight from from sector weight.) $ジロー グループ クラスC(Z.US)$+4% (Bank of America double upgraded the stock to buy, citing its improved growth outlook despite a challenging macroeconomic environment.) $ホロジック(HOLX.US)$+2.8% (The women's diagnostics provider reported fiscal first quarter revenue Sunday that topped its most recent guidance and Wall Str...
Gapping up $Abiomed(ABMD.US)$+51.6% in premarket trading after agreeing to be acquired by$ジョンソン・エンド・ジョンソン(JNJ.US)$in a nearly $16.6 billion deal. J&J will pay $380 per share for the maker of heart, lung and kidney treatments, and will add a contingent value right worth up to $35 per share if certain milestones are achieved. $ウーバー・テクノロジーズ(UBER.US)$+8.8% (it reported better-than-expected quarterly revenue as gross bookings ...
Upgrades •$ボルグワーナー(BWA.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $48 (from $43) •$エクスペンシファイ(EXFY.US)$: BofA Securities Upgrades to Buy from Neutral - PT $25 (from $20) •$グラブ・ホールディングス(GRAB.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $3 •$フーリハン・ローキー(HLI.US)$: Morgan Stanley Upgrades to Equalweight from Underweight - PT $82 (from $95) •$JPモルガン・チェース(JPM.US)$: Berenberg Upgrades to Hold from Sell - PT ...
ホロジックに関するコメント
Update
コラムToday's Pre-Market Stock Movers: LULU, TSLA, BBBY, Z and More
$ビザ(V.US)$ +1.1%, $マスターカード(MA.US)$ +1.7% (Keybanc upgraded their ratings to overweight from from sector weight.)
$ジロー グループ クラスC(Z.US)$ +4% (Bank of America double upgraded the stock to buy, citing its improved growth outlook despite a challenging macroeconomic environment.)
$ホロジック(HOLX.US)$ +2.8% (The women's diagnostics provider reported fiscal first quarter revenue Sunday that topped its most recent guidance and Wall Str...
コラムToday's Pre-Market Stock Movers: UBER, SOFI, PFE, ABMD and More
$Abiomed(ABMD.US)$ +51.6% in premarket trading after agreeing to be acquired by $ジョンソン・エンド・ジョンソン(JNJ.US)$ in a nearly $16.6 billion deal. J&J will pay $380 per share for the maker of heart, lung and kidney treatments, and will add a contingent value right worth up to $35 per share if certain milestones are achieved.
$ウーバー・テクノロジーズ(UBER.US)$ +8.8% (it reported better-than-expected quarterly revenue as gross bookings ...
コラムTop upgrades and downgrades on 7/20: GOOGL, NFLX, BABA, ZM and more
• $アルベマール(ALB.US)$ : KeyBanc Upgrades to Sector Weight from Underweight
• $アリババ・グループ・ホールディング(BABA.US)$ : Bernstein Upgrades to Outperform from Market Perform - PT $130
• $チェック・ポイント・ソフトウェア・テクノロジーズ(CHKP.US)$ : BofA Securities Upgrades to Buy from Underperform
• $シェブロン(CVX.US)$ : HSBC Upgrades to Buy from Hold - PT $167
• $FMC(FMC.US)$ : KeyBanc Upgrades to Overweight from Sector Weight - PT $122
• $ネットフリックス(NFLX.US)$ : Stifel U...
コラムTop upgrades and downgrades on 7/18: JPM, GRAB, GM, KHC and more
• $ボルグワーナー(BWA.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $48 (from $43)
• $エクスペンシファイ(EXFY.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $25 (from $20)
• $グラブ・ホールディングス(GRAB.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $3
• $フーリハン・ローキー(HLI.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $82 (from $95)
• $JPモルガン・チェース(JPM.US)$ : Berenberg Upgrades to Hold from Sell - PT ...
コラムToday's pre-market stock movers: TWTR, NIU, OCGN, SBUX and more
• $Twitter (Delisted)(TWTR.US)$ +20.5% (Elon Musk discloses 9.2% passive stake)
• $キャムテック(CAMT.US)$ +9.6%, $ペリオン・ネットワーク(PERI.US)$ +6.6% (In reaction to earnings/guidance)
• $ニウ・テクノロジーズ(NIU.US)$ +5% (reports QI sales volume increased 9.4% yr/yr)
• $Iron Spark I Inc(ISAA.US)$ +3.4% (Hypebeast plans to list on NASDAQ through Merger with Iron Spark I)
• $ガトス・シルバー(GATO.US)$ +2.3% (Provides Bi-Weekly Status Report)
• $ヴァーヴ・セラピューティクス(VERV.US)$ +1.8% (re...
コラムTop upgrades and downgrades on 4/4
• $DCP Midstream(DCP.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $42 (from $36)
• $レスリーズ(LESL.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $27 (from $26)
• $ロジテック・インターナショナル(LOGI.US)$ : Goldman Sachs Upgrades to Buy from Neutral
• $ニオ(NIO.US)$ : UBS Upgrades to Buy from Neutral - PT $32 (from $46)
• $オリーズ・バーゲン・アウトレット・ホールディングス(OLLI.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $65 (from $45)
• $ORICファーマシューティカルズ(ORIC.US)$ : Citigro...
まだコメントはありません